Disclosures for "Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS): The Caregiver Perspective")
-
Dr. Shah has nothing to disclose.
-
Dr. Andrews has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Andrews has stock in Takeda Pharmaceuticals.
-
Ms. Nacson has received personal compensation for serving as an employee of Clinical Outcomes Solutions. Ms. Nacson has received personal compensation for serving as an employee of IQVIA.
-
Dr. Symonds has nothing to disclose.
-
Miss Hughes has nothing to disclose.
-
Dr. Benitez has received personal compensation for serving as an employee of Takeda .
-
Miss Sams has nothing to disclose.